Novo Nordisk A/S
$39.12
▼
-0.76%
2026-04-22 10:12:13
www.novonordisk.com
NYQ: NVO
Explore Novo Nordisk A/S stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$131.02 B
Current Price
$39.12
52W High / Low
$533.4 / $224.25
Stock P/E
10.82
Book Value
$6.83
Dividend Yield
4.54%
ROCE
39.01%
ROE
60.7%
Face Value
—
EPS
$3.62
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
68,794
Beta
0.27
Debt / Equity
67.49
Current Ratio
0.8
Quick Ratio
0.57
Forward P/E
10.87
Price / Sales
0.54
Enterprise Value
$270.73 B
EV / EBITDA
1.77
EV / Revenue
0.88
Rating
Buy
Target Price
$47.87
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Strong operating margin profile.
- Net margin remains healthy.
- Valuation is not stretched on P/E basis.
- Meaningful dividend yield is available.
Cons
- Current ratio suggests tighter short-term liquidity.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Medicus Pharma Ltd. | $0.34 | — | $13.54 M | — | -27863.04% | -29.81% | $8.94 / $0.29 | $-0 |
| 2. | AstraZeneca PLC | $196.47 | 30 | $305.64 B | 1.58% | 15.97% | 22.84% | $15,730 / $9,651 | $31.38 |
| 3. | AbbVie Inc. | NOT FOUND | 86.59 | $360.82 B | 3.4% | 22.16% | 62.25% | $244.81 / $168.54 | $-1.85 |
| 4. | Organon & Co. | $9.26 | 12.89 | $2.41 B | 0.86% | 11.7% | 30.56% | $13.24 / $5.69 | $2.89 |
| 5. | Novartis AG | $147.76 | 20.66 | $301.93 B | 3.13% | 21.09% | 30.81% | $131 / $87.89 | $24.18 |
| 6. | Nasus Pharma Ltd. | $2.86 | — | $19.29 M | — | -172.62% | 2637.84% | $9.99 / $1.98 | $0.31 |
| 7. | Biogen Inc. | $191.44 | 21.83 | $28.09 B | — | 9.46% | 7.39% | $202.41 / $114.66 | $124.36 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 79.14 B | 74.98 B | 76.86 B | 78.09 B | 85.68 B | — |
| Operating Profit | 31.74 B | 23.68 B | 33.45 B | 38.79 B | 36.74 B | — |
| Net Profit | 26.89 B | 20.01 B | 26.5 B | 29.03 B | 28.23 B | — |
| EPS in Rs | 8 | 5.95 | 7.88 | 8.63 | 8.39 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 309.06 B | 290.4 B | 232.26 B | 176.95 B |
| Operating Profit | 127.66 B | 128.34 B | 102.57 B | 74.81 B |
| Net Profit | 102.43 B | 100.99 B | 83.68 B | 55.52 B |
| EPS in Rs | 30.46 | 30.03 | 24.89 | 16.51 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 542.9 B | 465.63 B | 314.49 B | 241.26 B |
| Total Liabilities | 348.86 B | 322.14 B | 207.93 B | 157.77 B |
| Equity | 194.05 B | 143.49 B | 106.56 B | 83.49 B |
| Current Assets | 172.45 B | 161.79 B | 139.65 B | 108.19 B |
| Current Liabilities | 215.66 B | 217.61 B | 169.66 B | 120.94 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 119.1 B | 120.97 B | 108.91 B | 78.89 B |
| Investing CF | -79.16 B | -128.9 B | -43.89 B | -24.92 B |
| Financing CF | -28.41 B | 8.73 B | -63.16 B | -51.8 B |
| Free CF | 28.99 B | 69.66 B | 70.01 B | 64.13 B |
| Capex | -90.11 B | -51.31 B | -38.9 B | -14.75 B |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 6.43% | 25.03% | 31.26% | — |
| Earnings Growth % | 1.43% | 20.68% | 50.71% | — |
| Profit Margin % | 33.14% | 34.78% | 36.03% | 31.38% |
| Operating Margin % | 41.3% | 44.19% | 44.16% | 42.28% |
| Gross Margin % | 80.98% | 84.67% | 84.6% | 83.92% |
| EBITDA Margin % | 50.71% | 50.94% | 49.35% | 43.4% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-30 | $1.275 |
| 2025-08-18 | $0.584 |
| 2025-03-31 | $1.099 |
| 2024-08-16 | $0.513 |
| 2024-03-22 | $0.93 |
Stock Splits
| Date | Split |
|---|---|
| 2023-09-20 | 1:2 |